Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
YiCeng plaster (Yi Ceng Gao) is a Traditional Chinese Medicine (TCM) topical preparation developed and utilized by Kunshan Third People's Hospital for the treatment of knee osteoarthritis and other rheumatic conditions. Formulated as a plaster for external application, it is a hospital-made preparation (院内制剂) that typically incorporates medicinal ants (such as *Polyrhachis vicina*) along with various herbal extracts intended to dispel wind, remove dampness, and alleviate pain. In clinical research, YiCeng plaster has been evaluated for its efficacy in reducing pain and improving joint function in patients with knee osteoarthritis, often compared against standard topical non-steroidal anti-inflammatory drugs (NSAIDs) like diclofenac gel.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on YiCeng plaster.